Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Kostas Biliouris's Stock Ratings
BMO Capital Analyst
Kostas Biliouris is an analyst at BMO Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/17/2025
Overall Average Return
-%
Smart Score
Overall Average Return Percentile
-
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 06/16/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.55 | 224.83% | Kostas Biliouris35% | $120 → $70 | Downgrade | Outperform → Market Perform | Get Alert |
| 05/28/2025 | RCKT | Buy Now | Rocket Pharmaceuticals | $2.79 | 186.23% | Kostas Biliouris35% | $30 → $8 | Maintains | Outperform | Get Alert |
| 03/12/2025 | RNA | Buy Now | Avidity Biosciences | $30.51 | 135.99% | Kostas Biliouris35% | → $72 | Initiates | → Outperform | Get Alert |
| 03/12/2025 | RCKT | Buy Now | Rocket Pharmaceuticals | $2.79 | 1688.91% | Kostas Biliouris35% | → $50 | Initiates | → Outperform | Get Alert |
| 03/12/2025 | DYN | Buy Now | Dyne Therapeutics | $11.23 | 345.24% | Kostas Biliouris35% | → $50 | Initiates | → Outperform | Get Alert |
| 03/04/2025 | SLN | Buy Now | Silence Therapeutics | $5.19 | 381.7% | Kostas Biliouris35% | $67 → $25 | Maintains | Outperform | Get Alert |
| 02/20/2025 | IONS | Buy Now | Ionis Pharmaceuticals | $35.63 | 26.3% | Kostas Biliouris35% | $60 → $45 | Maintains | Market Perform | Get Alert |
| 01/10/2025 | NTLA | Buy Now | Intellia Therapeutics | $9.86 | 407.1% | Kostas Biliouris35% | $70 → $50 | Maintains | Outperform | Get Alert |
| 01/10/2025 | DTIL | Buy Now | Precision BioSciences | $5.13 | 562.77% | Kostas Biliouris35% | $34 → $34 | Upgrade | Market Perform → Outperform | Get Alert |
| 09/16/2024 | CNTA | Buy Now | Centessa Pharmaceuticals | $12.72 | 175.16% | Kostas Biliouris35% | $20 → $35 | Maintains | Outperform | Get Alert |
| 09/09/2024 | CNTA | Buy Now | Centessa Pharmaceuticals | $12.72 | 57.23% | Kostas Biliouris35% | $15 → $20 | Maintains | Outperform | Get Alert |
| 08/15/2024 | MGX | Buy Now | Metagenomi | $1.50 | 1037.12% | Kostas Biliouris35% | $22 → $17 | Maintains | Outperform | Get Alert |
| 08/02/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $35.63 | 68.4% | Kostas Biliouris35% | $67 → $60 | Downgrade | Outperform → Market Perform | Get Alert |
| 07/18/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.57 | 775.27% | Kostas Biliouris35% | $63 → $40 | Maintains | Outperform | Get Alert |
| 07/03/2024 | LEGN | Buy Now | Legend Biotech | $34.70 | 159.37% | Kostas Biliouris35% | $90 → $90 | Maintains | Outperform | Get Alert |
| 06/24/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $305.25 | -23.34% | Kostas Biliouris35% | $234 → $234 | Maintains | Outperform | Get Alert |
| 06/24/2024 | SRPT | Buy Now | Sarepta Therapeutics | $21.55 | 828.07% | Kostas Biliouris35% | $170 → $200 | Maintains | Outperform | Get Alert |
| 06/18/2024 | SRPT | Buy Now | Sarepta Therapeutics | $21.55 | 688.86% | Kostas Biliouris35% | $170 → $170 | Maintains | Outperform | Get Alert |
| 06/14/2024 | SRPT | Buy Now | Sarepta Therapeutics | $21.55 | 688.86% | Kostas Biliouris35% | $170 → $170 | Maintains | Outperform | Get Alert |
| 05/15/2024 | KRRO | Buy Now | Korro Bio | $13.17 | 811.16% | Kostas Biliouris35% | $120 → $120 | Maintains | Outperform | Get Alert |
| 05/10/2024 | NTLA | Buy Now | Intellia Therapeutics | $9.86 | 609.94% | Kostas Biliouris35% | $62 → $70 | Maintains | Outperform | Get Alert |
| 04/01/2024 | CNTA | Buy Now | Centessa Pharmaceuticals | $12.72 | 17.92% | Kostas Biliouris35% | $15 → $15 | Maintains | Outperform | Get Alert |
| 04/01/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.57 | 1278.56% | Kostas Biliouris35% | $70 → $63 | Maintains | Outperform | Get Alert |
| 03/27/2024 | BEAM | Buy Now | Beam Therapeutics | $17.19 | 231.59% | Kostas Biliouris35% | → $57 | Maintains | Outperform | Get Alert |
| 03/27/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $305.25 | -23.34% | Kostas Biliouris35% | $234 → $234 | Maintains | Outperform | Get Alert |
| 03/26/2024 | KRRO | Buy Now | Korro Bio | $13.17 | 811.16% | Kostas Biliouris35% | $120 → $120 | Reiterates | Outperform → Outperform | Get Alert |
| 03/05/2024 | MGX | Buy Now | Metagenomi | $1.50 | 1371.57% | Kostas Biliouris35% | → $22 | Initiates | → Outperform | Get Alert |
| 02/27/2024 | KRRO | Buy Now | Korro Bio | $13.17 | 811.16% | Kostas Biliouris35% | → $120 | Initiates | → Outperform | Get Alert |
| 02/05/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.57 | 1431.73% | Kostas Biliouris35% | $50 → $70 | Maintains | Outperform | Get Alert |
| 01/31/2024 | BBIO | Buy Now | BridgeBio Pharma | $39.96 | -7.41% | Kostas Biliouris35% | → $37 | Initiates | → Market Perform | Get Alert |
| 01/31/2024 | SLN | Buy Now | Silence Therapeutics | $5.19 | 1190.94% | Kostas Biliouris35% | → $67 | Initiates | → Outperform | Get Alert |
| 01/31/2024 | SRPT | Buy Now | Sarepta Therapeutics | $21.55 | 688.86% | Kostas Biliouris35% | → $170 | Initiates | → Outperform | Get Alert |
| 11/10/2023 | NTLA | Buy Now | Intellia Therapeutics | $9.86 | 528.8% | Kostas Biliouris35% | $64 → $62 | Maintains | Outperform | Get Alert |
| 11/03/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $55.72 | 79.47% | Kostas Biliouris35% | $102 → $100 | Maintains | Outperform | Get Alert |
| 10/10/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $305.25 | -23.34% | Kostas Biliouris35% | $250 → $234 | Maintains | Outperform | Get Alert |
| 10/09/2023 | PRME | Buy Now | Prime Medicine | $1.71 | 1011.11% | Kostas Biliouris35% | → $19 | Initiates | → Outperform | Get Alert |
| 07/25/2023 | CNTA | Buy Now | Centessa Pharmaceuticals | $12.72 | 17.92% | Kostas Biliouris35% | $11 → $15 | Maintains | Outperform | Get Alert |
| 07/05/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $55.72 | 83.06% | Kostas Biliouris35% | → $102 | Upgrade | Market Perform → Outperform | Get Alert |
| 05/05/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $305.25 | -18.1% | Kostas Biliouris35% | $200 → $250 | Upgrade | Market Perform → Outperform | Get Alert |
| 05/05/2023 | NTLA | Buy Now | Intellia Therapeutics | $9.86 | 549.09% | Kostas Biliouris35% | $57 → $64 | Maintains | Outperform | Get Alert |
| 04/25/2023 | LEGN | Buy Now | Legend Biotech | $34.70 | 159.37% | Kostas Biliouris35% | $79 → $90 | Maintains | Outperform | Get Alert |
| 03/14/2023 | DTIL | Buy Now | Precision BioSciences | $5.13 | -22.03% | Kostas Biliouris35% | $7 → $4 | Downgrade | Outperform → Market Perform | Get Alert |
| 03/14/2023 | NTLA | Buy Now | Intellia Therapeutics | $9.86 | 478.09% | Kostas Biliouris35% | $54 → $57 | Upgrade | Market Perform → Outperform | Get Alert |
| 03/07/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $55.72 | 83.06% | Kostas Biliouris35% | $107 → $102 | Maintains | Market Perform | Get Alert |
| 01/30/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $55.72 | 92.03% | Kostas Biliouris35% | → $107 | Initiates | → Market Perform | Get Alert |
| 01/30/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.57 | 994.09% | Kostas Biliouris35% | → $50 | Initiates | → Outperform | Get Alert |
| 01/06/2023 | GRPH | Buy Now | Graphite Bio | — | — | Kostas Biliouris35% | $14 → $7 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/20/2022 | BEAM | Buy Now | Beam Therapeutics | $17.19 | 283.94% | Kostas Biliouris35% | $61 → $66 | Upgrade | Market Perform → Outperform | Get Alert |
| 08/11/2022 | CNTA | Buy Now | Centessa Pharmaceuticals | $12.72 | -13.52% | Kostas Biliouris35% | $19 → $11 | Maintains | Outperform | Get Alert |
| 07/18/2022 | VERV | Buy Now | Verve Therapeutics | $11.09 | 459.06% | Kostas Biliouris35% | $48 → $62 | Maintains | Outperform | Get Alert |
| 06/17/2022 | LEGN | Buy Now | Legend Biotech | $34.70 | 121.9% | Kostas Biliouris35% | → $77 | Initiates | → Outperform | Get Alert |
| 06/17/2022 | VERV | Buy Now | Verve Therapeutics | $11.09 | 332.82% | Kostas Biliouris35% | → $48 | Initiates | → Outperform | Get Alert |
| 06/17/2022 | CRSP | Buy Now | CRISPR Therapeutics | $43.45 | 125.55% | Kostas Biliouris35% | → $98 | Initiates | → Outperform | Get Alert |
| 06/17/2022 | CNTA | Buy Now | Centessa Pharmaceuticals | $12.72 | 49.37% | Kostas Biliouris35% | → $19 | Initiates | → Outperform | Get Alert |
| 06/17/2022 | DTIL | Buy Now | Precision BioSciences | $5.13 | 36.45% | Kostas Biliouris35% | → $7 | Initiates | → Outperform | Get Alert |
| 06/17/2022 | GRPH | Buy Now | Graphite Bio | — | — | Kostas Biliouris35% | → $12 | Initiates | → Outperform | Get Alert |
| 06/17/2022 | BEAM | Buy Now | Beam Therapeutics | $17.19 | 138.51% | Kostas Biliouris35% | → $41 | Initiates | → Market Perform | Get Alert |
| 06/17/2022 | NTLA | Buy Now | Intellia Therapeutics | $9.86 | 447.67% | Kostas Biliouris35% | → $54 | Initiates | → Market Perform | Get Alert |
